Highest-materiality recent filing
1606 Corp. signs definitive agreement to acquire 51% of Sim Agro Inc. for stock and assumed debt
Acquiring 51% of Sim Agro; consideration: 150M shares at closing plus 100M shares or $2.1M cash in Jan 2027.
1606 Corp. issues $1.885M convertible promissory note to former CEO Gregory Lambrecht
Note principal of $1,885,050 issued effective Dec 31, 2025 with same maturity date.
1606 Corp. signs agreement to acquire 132-acre data-center-ready property in Texas for $11.2M
Purchase price $11.2M ($7M cash plus assumption of ~$4.2M mechanic's lien).
1606 Corp. agrees to buy Texas property for $11.2M in cash plus assumed lien
Purchase price $11,168,864: $7M cash at closing plus assumption of mechanic's lien.
Total consideration $11.67M: $7.5M cash plus assumption of $4.17M debt; $500K earnest money upon definitive agreement.
1606 Corp. signs nonbinding term sheet to be acquired by Sim Agro Inc.
Sim Agro Inc., a private power and sustainable energy firm, will acquire a controlling interest in 1606 Corp. (CBDW).
1606 Corp. increases note principal to $1.83M from ex-CEO Lambrecht; adds 25% discount conversion
October 21, 2025 addendum raises promissory note principal to $1,829,550 from $1,528,550.
1606 Corp. extends $20M equity line with GHS Investments through May 2027
Amendment dated May 14, 2025 extends termination to 24 months from that date, replacing original Feb 2023 term.
1606 Corp. issues $1.53M promissory note to former CEO Gregory Lambrecht
Principal amount of $1,528,550, amended from $1,220,550, issued March 31, 2025.
1606 Corp. signs non-binding LOI for $1M controlling stake by Garfield/Arnold group
Private group led by Jon Garfield and Chuck Arnold to acquire controlling position for $1 million.
1606 Corp. announces AI services partnership with GPO Plus to enhance PRISM+ platform
1606 Corp. will provide AI development, data integration, edge computing, training, and performance monitoring for GPOX's PRISM+ platform.
Amended and restated promissory note principal amount $1,365,550 issued to former CEO Gregory Lambrecht on Dec 31, 2024.
1606 Corp. target Adnexus merges with Sanctum for HIV and COVID-19 assets
Adnexus Biotechnologies completed acquisition of Sanctum Therapeutics' core tech assets for HIV and SARS-CoV-2.
1606 Corp amends promissory note to former CEO, increasing principal to $1.22M
Issued Amended and Restated Promissory Note to former CEO Gregory Lambrecht on Nov 1, 2024 for $1,220,550.
1606 Corp. dismisses auditor Turner, Stone; engages Salberg & Company
Dismissed Turner, Stone & Company as independent auditor effective October 21, 2024; no disagreements.
1606 Corp. appoints Austen Lambrecht as CEO and Chairman, effective May 31, 2024
Austen Lambrecht named CEO and Chairman of the Board, succeeding Greg Lambrecht.
CEO Austen Lambrecht gains voting control via Series B preferred stock gift from father
Gregory Lambrecht gifted 60 shares of Series B Preferred Stock to his son Austen Lambrecht, the current CEO.
Gregory Lambrecht resigned as CEO, CFO, and Chairman effective May 28, 2024, not due to any disagreement with the company.
Effective May 28, 2024, the Board of Directors of the Company (with Austen Lambrecht abstaining) appointed Austen Lambrecht, age 26, as Chief Executive Officer (Principal Executive Officer), Chief Financial Officer (Principal Financial and Accounting Officer), and Chairman of the Board of the Company.
Effective May 28, 2024, Gregory Lambrecht resigned as the Chief Executive Officer, Chief Financial Officer, and Chairman of the Board of 1606 Corp., a Nevada corporation (the “ Company ”).
Max materiality 0.75 · Median 0.53 · Most common event other_material